Company profile
BlinkLab Limited (ASX:BB1)
Digital Sensory Phenotyping for Psychiatric Disorders
- Industry
- Biotechnology Research
- Employees
- 35
- Headquarters
- Delft, Zuid-Holland
- Founded
- 2021
- LinkedIn followers
- 1,343
- Office locations
- 3
BlinkLab Limited (ASX:BB1) company summary
BlinkLab Limited (ASX:BB1) is a company in the Biotechnology Research industry, headquartered in Delft, Zuid-Holland, founded in 2021. On LinkedIn the company has around 35 employees and 1,343 followers. The company lists 3 office locations.
What technology does BlinkLab Limited (ASX:BB1) use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About BlinkLab Limited (ASX:BB1)
BlinkLab Limited (ASX.BB1), a company founded by neuroscientists at Princeton University, over the past several years has fully developed a smartphone based diagnostic platform for autism, ADHD, schizophrenia, and other neurodevelopmental conditions. Our most advanced product is an autism diagnostic test that leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as 18 months old. This marks a significant advancement, considering traditional diagnoses typically occur around five years of age, often missing the crucial early window for effective intervention. BlinkLab is led by an experienced management team and directors with a proven track record in building companies and vast knowledge in digital healthcare, computer vision, AI and machine learning. Our Scientific Advisory Board consists of leading experts in the field of autism and brain development allowing us to bridge most advanced technological innovations with groundbreaking scientific research.
Where is BlinkLab Limited (ASX:BB1) located?
BlinkLab Limited (ASX:BB1) lists 3 office locations.
Compare companies similar to BlinkLab Limited (ASX:BB1)
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
BlinkLab Limited (ASX:BB1) blinklab.org | Biotechnology Research | 35 | 2021 | Delft, Zuid-Holland |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about BlinkLab Limited (ASX:BB1)
What does BlinkLab Limited (ASX:BB1) do?
BlinkLab Limited (ASX.BB1), a company founded by neuroscientists at Princeton University, over the past several years has fully developed a smartphone based diagnostic platform for autism, ADHD, schizophrenia, and other neurodevelopmental conditions. Our most advanced product is an autism diagnostic test that leverages the power of smartphones, AI and machine learning to deliver screening tests specifically designed for children as young as 18 months old. This marks a significant advancement, considering traditional diagnoses typically occur around five years of age, often missing the crucial early window for effective intervention. BlinkLab is led by an experienced management team and directors with a proven track record in building companies and vast knowledge in digital healthcare, computer vision, AI and machine learning. Our Scientific Advisory Board consists of leading experts in the field of autism and brain development allowing us to bridge most advanced technological innovations with groundbreaking scientific research.
How many employees does BlinkLab Limited (ASX:BB1) have?
BlinkLab Limited (ASX:BB1) has around 35 employees on LinkedIn.
Where is BlinkLab Limited (ASX:BB1) headquartered?
BlinkLab Limited (ASX:BB1) is headquartered in Delft, Zuid-Holland.
Where does BlinkLab Limited (ASX:BB1) have offices?
BlinkLab Limited (ASX:BB1) lists 3 office locations, including Delft, Zuid-Holland, NL; Princeton, New Jersey, US; Sydney Central Business District, NSW, AU.
When was BlinkLab Limited (ASX:BB1) founded?
BlinkLab Limited (ASX:BB1) was founded in 2021.
Build a lead list from companies like BlinkLab Limited (ASX:BB1)
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.